Here Is How Much Upside SpaceX Stock Has Left After Its Post-IPO Sell-off

SpaceX shares (post-June 12 IPO) have pulled back to about $170, with valuation still extremely rich at ~$2.16T (~116x trailing revenue and ~22x 2028 revenue). The article flags near-term upside as limited despite Nasdaq-100 inclusion on July 7 (index funds will buy), because lockup expirations starting late July/early August through year-end could trigger insider/early-investor selling. With the company still unprofitable and dependent on debt/dilutive deals, the setup is broadly supportive for a floor but capped for gains into 2026.

Analysis

The important mechanism here is not "new demand" but demand timing. Nasdaq-100 inclusion can force mechanical buying from passive vehicles, yet at this valuation that flow is more likely to create a temporary liquidity backstop than a durable re-rate; once the rebalance is done, the stock is still priced for flawless execution, leaving little room for error. In other words, the inclusion can mute downside for a few sessions, but it does not fix the fundamental mismatch between price and realizable cash generation.

The bigger overhang is supply. Lockup expiry creates a second wave of stock available to the market just as the passive bid fades, which is exactly the setup that tends to transfer shares from momentum buyers to value-sensitive holders. That is bearish for late-stage private-market comps and for any adjacent names trading on a similar "future platform" multiple, because a de-rating in one flagship growth asset can spill into the broader long-duration tech complex.

On the risk side, the near-term thesis can be invalidated by a clean post-inclusion squeeze if borrow is tight and the float remains constrained; that would be a days-to-weeks event, not a change in fundamentals. Over 1-3 months, secondary sales, debt financing, or any sign that growth requires external capital should pressure the multiple further. Over 6-18 months, the only real upside catalyst is a step-change in operational cadence; absent that, the current price likely already discounts too much of the 2028 story.

My contrarian read is that the market may be underestimating how quickly technical support can become supply once the inclusion window closes. The consensus seems to treat index addition as bullish by default, but in a name this expensive, the inclusion is more likely to compress volatility temporarily than to expand valuation permanently. That makes this more of a fading opportunity than a chase-the-breakout setup.

Key Decisions for Investors

• Initiate a tactical short SPCX into the Nasdaq-100 inclusion window, with a 2-6 week horizon and a cover target into the first lockup tranche; thesis is that passive demand is front-loaded while supply is back-loaded.
• Pair trade: long QQQ / short SPCX for 1-3 months to isolate the technical overhang from broad growth-beta; target SPCX underperformance versus QQQ of 15-25% if lockup selling begins to matter.
• If SPCX options/borrow are liquid, buy 1-3 month put spreads after the inclusion pop fades; use defined risk because the main failure mode is a short squeeze on constrained float.
• Set an alert for insider selling, secondary offerings, or debt issuance in late July through year-end; any accelerated supply should be treated as a confirmation signal for the short thesis.
• Do not chase a standalone long in NDAQ on this event; any index-provider benefit is too small to be investable relative to the stock-specific supply risk in SPCX.